SPIA
INMB icon

Steward Partners Investment Advisory’s INmune Bio INMB Stock Holding History

Steward Partners Investment Advisory’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$8 – 4501
2025
Q4 		$8 Hold
5
– – ﹤0.01% 4291
2025
Q3 		$10 Buy
+5
New +$11 ﹤0.01% 4245
2025
Q2 		– Sell
-350
Closed -$2.73K – 4192
2025
Q1 		$2.73K Buy
+350
New +$2.78K ﹤0.01% 3570
2021
Q2 		– Sell
-500
Closed -$5.94K – 7243
2021
Q1 		$5.94K Buy
+500
New +$9K ﹤0.01% 2968

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Steward Partners Investment Advisory's INMB Position: Q1 2026 in Review

Steward Partners Investment Advisory sold out of INmune Bio (INMB) in Q1 2026, closing a stake of 5 shares — an estimated $8 sold.

Steward Partners Investment Advisory first reported a position in INMB in Q1 2021 and held it in 4 quarters. The position peaked at $5.94K in Q1 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Steward Partners Investment Advisory reported no remaining INmune Bio position as of Q1 2026 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 5 INmune Bio shares in Q1 2026, an estimated $8.
  • Steward Partners Investment Advisory first reported a position in INmune Bio in Q1 2021 and held it in 4 quarters.
  • Steward Partners Investment Advisory's INmune Bio position peaked at $5.94K in Q1 2021.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.